Market Overview

Benzinga's Top Initiations

Share:
Related CS
Goldman Sachs, Other Banks Expects Tax Reform To Have Big One-Time Impacts
30 Stocks Moving In Thursday's Pre-Market Session
Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Credit Suisse Group ... (GuruFocus)
Related IMAX
Is Imax Losing Its Edge In A Changing Movie Industry? Piper Jaffray Downgrades On Multiple Stock Pressures
Benzinga's Top Upgrades, Downgrades For January 10, 2018

Analysts at ING Group initiated coverage on shares of Credit Suisse Group (NYSE: CS) with a “sell” rating. Credit Suisse's shares closed at $18.33 on Friday. Credit Suisse's PEG ratio is 0.66.

JP Morgan initiated coverage on shares of IMAX (NYSE: IMAX) with an “overweight” rating. IMAX's stock closed at $24.03 on Friday. IMAX's trailing-twelve-month ROE is 10.51%.

William Blair initiated coverage on shares of Gartner (NYSE: IT) with an “outperform” rating. Gartner's shares closed at $43.05 on Friday. Gartner's trailing-twelve-month revenue is $1.51 billion.

Analysts at Needham initiated coverage on shares of Cytokinetics (NASDAQ: CYTK) with a “buy” rating. Cytokinetics's shares closed at $0.64 on Friday. Cytokinetics had $43.08 million in total cash for the latest quarter.

Latest Ratings for CS

DateFirmActionFromTo
Nov 2017MacquarieUpgradesUnderperformNeutral
Sep 2017Societe GeneraleUpgradesHoldBuy
Dec 2016JP MorganUpgradesUnderweightOverweight

View More Analyst Ratings for CS
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (CYTK + CS)

View Comments and Join the Discussion!